Recent news on Mycophenolate

Orphan News :: Treatment & Health  -  May 24, 2007
Checkbiotech.org (press release),This randomized, double-blind, placebo-controlled comparison study is designed to investigate the efficacy and safety of mycophenolate mofetil in patients

Early Results of the CellCept(R) Spare the Nephron Study Examine ...  -  May 7, 2007
PR Newswire (press release),...investigating a novel kidney-sparing treatment protocol using CellCept(R) (mycophenolate mofetil) were presented at the American Transplant Congress.

Early Results of the CellCept(R) Spare the Nephron Study Examine ...  -  May 7, 2007
Earthtimes.orgSAN FRANCISCO, May 7 -- Interim results from a multicenter trial investigating a novel kidney-sparing treatment protocol using CellCept(R) (mycophenolate

The Ethical Issues of Uterine Transplantation: Debunking the ...  -  Apr 30, 2007
Student Operated Press,As for other agents, such as rapamycin and mycophenolate mofetil, their effects are still unknown. “This would currently be a highly speculative

Advagraf® Now Approved Across Europe As A Once-daily ...  -  Apr 30, 2007
Medical News Today (press release),All patients received standard basiliximab induction, mycophenolate mofetil (MMF) and corticosteroids. The primary efficacy endpoint was the efficacy

Renal transplantation in 1-5 year olds  -  Apr 26, 2007
News-Medical.net,The primary immunosuppressant therapy consisted of cyclosporine in 61% of the patients, tacrolimus in 39%, mycophenolate in 49% and azathioprine in 51%.

Renal transplantation in children younger than 6 years old  -  26 Apr 2007
SpiritIndia,The primary immunosuppressant therapy consisted of cyclosporine in 61% of the patients, tacrolimus in 39%, mycophenolate in 49% and azathioprine in 51%.

Renal Transplantation in Children Younger than 6 Years Old  -  Apr 23, 2007
UroToday,The primary immunosuppressant therapy consisted of cyclosporine in 61% of the patients, tacrolimus in 39%, mycophenolate in 49% and azathioprine in 51%.

Case 12-2007 — A 56-Year-Old Woman with Renal Failure after Heart ...  -  Apr 18, 2007
New England Journal of Medicine (subscription),The inosine monophosphate dehydrogenase inhibitors, mycophenolate mofetil and mycophenolic acid, target T and B lymphocytes, since in contrast to all other

Oral pemphigus vulgaris  -  Apr 20, 2007
RDH,Several new treatments such as the use of intravenous immunoglobulin, monoclonal antibodies, mycophenolate mofetil (CellCept) are used as well.

AVN944 Shows Potent Antiproliferative Activity in Human ...  -  Apr 19, 2007
PipelineReview.com (press release),...with AVN944 inhibited the growth of new blood vessels to a similar or greater degree than mycophenolate mofetil, an FDA-approved immunosuppressant drug.

Study suggests mycophenolate mofetil effective for pediatric uveitis  -  Mar 9, 2007
OSN SuperSite (subscription),A study by researchers in Germany found that most children with uveitis who were treated with mycophenolate mofetil were able to discontinue or reduce their

FDA Action Letter Issued for Prograf SNDA  -  Mar 21, 2007
Facts and Comparisons,The FDA has issued an action letter to Astellas Pharma for its SNDA for Prograf (tacrolimus) in combination with mycophenolate mofetil (CellCept) as adjunct

Biocon Limited Unveils A Comprehensive Portfolio of Renal Therapy ...  -  Mar 8, 2007
HULIQ,The company is a leading supplier of Mycophenolate mofetil, Tacrolimus and Sirolimus APIs for major Indian nephrology brands".

Patient wins drug appeal  -  Mar 14, 2007
Wimbledon Guardian,In December last year Joanna's specialist doctor made a case to Kingston PCT to prescribe her the drug mycophenolate, which he believed was her best chance

Biocon Unveils Renal Therapies for Kidney Disorders  -  Mar 9, 2007
MedIndia,Renodapt (Mycophenolate Mofeti), Tacrograf (Tacrolimus), Cyclophil Me (Cyclosporine micro emulsion), Rapacan (Sirolimus) and Erypro (rHuEpo).

West Nile Virus Transmission Through Blood Transfusion—South ...  -  Mar 20, 2007
Journal of American Medical Association (subscription),...immunosuppressive therapy, including 750 mg of mycophenolate mofetil twice daily, 125 mg of cyclosporin twice daily, and 20 mg of prednisone daily.

Astellas expects stronger growth for Eligard in EU  -  Mar 23, 2007
Pharma Times (subscription),The agency expressed concerns in a letter that the combination of Prograf and Roche's CellCept (mycophenolate mofetil) could lead to an increase in

BD Biosciences and Roche Collaborate to Advance the Study of Cell ...  -  Mar 8, 2007
Drug Newswire (press release),Medicines discovered at Roche Palo Alto include CellCept(R) (mycophenolate mofetil), Valcyte(R) (valganciclovir) and Naprosyn(R) (naproxen).

Sudhar Murthy launches products of Biocon's Nephrology Division  -  Mar 8, 2007
Equity Bulls,The new immunosuppressants for renal therapy include RENODAPT (Mycophenolate Mofetil), TACROGRAF(Tacrolimus), CYCLOPHIL ME (Cyclosporine Micro Emulsion USP)

BD Biosciences and Roche Collaborate to Advance the Study of Cell ...  -  Feb 27, 2007
PipelineReview.com (press release),Medicines discovered at Roche Palo Alto include CellCept® (mycophenolate mofetil), Valcyte® (valganciclovir) and Naprosyn® (naproxen).

Roche Against Switch in Immunosuppressant Regimen  -  Feb 23, 2007
Medscape (subscription)...after being maintained on either tacrolimus or cyclosporine along with the company's immunosuppressant mycophenolate mofetil (MMF, CellCept),

Study Tests Oral Insulin To Prevent Type 1 Diabetes  -  Feb 4, 2007
Medical News Today (press release),Also under way is a study testing whether mycophenolate mofetil (MMF) or MMF plus daclizumab (DZB), drugs approved by FDA to prevent rejection after an

Clinical study of oral insulin's efficacy against type 1 diabetes ...  -  Feb 1, 2007
DailyIndia.com,Also under way is a study testing whether mycophenolate mofetil (MMF) or MMF plus daclizumab (DZB), drugs to prevent rejection after an organ transplant,

Roche Posts Outstanding Results for 2006  -  Feb 7, 2007
PharmaLive.com (press release),Transplantation - leading position maintained Sales of CellCept (mycophenolate mofetil) continued to post solid sales growth in 2006, driven by particularly

A 24-Year-Old Woman with Systemic Lupus Erythematosus, Seizures ...  -  Dec 20, 2006
New England Journal of Medicine (subscription),She had been treated continuously with corticosteroids, with the addition of methotrexate, azathioprine, mycophenolate, leflunomide, and etanercept at

Uncovering A New Reason Why Patients Respond Differently To The ...  -  Jan 16, 2007
Science Daily (press release)Transplant Rejection Drug Holds Promise For Inflammatory Eye Disease (September 3, 2005) -- The immunosuppressive drug mycophenolate mofetil,

Interstitial Lung Disease and Connective Tissue Disease  -  Jan 12, 2007
Medscape (subscription)Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.

A 24-Year-Old Woman with Systemic Lupus Erythematosus, Seizures ...  -  Dec 20, 2006
New England Journal of Medicine (subscription),She had been treated continuously with corticosteroids, with the addition of methotrexate, azathioprine, mycophenolate, leflunomide, and etanercept at

Dr. Hans-Joachim Bohm Named President of Roche Palo Alto  -  Dec 11, 2006
Drug Newswire (press release),Medicines discovered at Roche Palo Alto include CellCept(R) (mycophenolate mofetil), Valcyte(R) (valganciclovir) and Naprosyn(R) (naproxen).

Dr. Hans-Joachim Bohm Named President of Roche Palo Alto  -  Dec 11, 2006
Yahoo! News (press release)Medicines discovered at Roche Palo Alto include CellCept® (mycophenolate mofetil), Valcyte® (valganciclovir) and Naprosyn® (naproxen).

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional